Parliamentary Search

Written question asked by Keith Vaz (Labour) on Wednesday, 30 January 2019, in the House of Commons. It was due for an answer on Monday, 4 February 2019. It was answered by Steve Brine (Conservative) on Thursday, 7 February 2019 on behalf of the Department of Health and Social Care.

Diabetes: Medical Equipment

Question

To ask the Secretary of State for Health and Social Care, what representations his Department has made to the pharmaceutical company Abbott on the availability of FreeStyle Libre being issued to people with Type 1 diabetes from April 2019.

Answer

On 14 November 2018, it was announced that flash glucose monitors will be available on prescription for every patient who qualifies for them, in line with National Health Service clinical guidelines.

The Department has not made any representations to Abbott since.

Clinical commissioning groups (CCGs) are responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This should include consideration of access to diabetes technologies such as FreeStyle Libre.

Secondary information

Type
Written question
Reference
214473
Session
2017-19
Registered interest declared
Yes
Subjects
Diabetes Medical devices Abbott Brexit
Link
View this Written question on www.parliament.uk